Le cluster Prostatic Neoplasms (blood) - Prostatic Neoplasms (surgery)
| 000045 (2005) | Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing biochemical recurrence of prostate cancer. | |
| 000032 (2008) | Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. | |
| 000046 (2004) | Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma. | |
| 000067 (1998) | Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging. | |
| 000077 (1996) | Monoclonal antibody scan holds promise for prostate cancer staging. | |
| 000041 (2005) | The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. | |
| 000068 (1998) | Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study. | |
| 000076 (1996) | Radiation absorbed dose from indium-111-CYT-356. |
| This area was generated with Dilib version V0.5.76. |  |